Phosphaturic Tumor-Induced Osteomalacia

被引:0
|
作者
Ashouri, Diana [1 ]
Kastoon, Tony [2 ]
机构
[1] Univ Calif Riverside, Internal Med, Riverside, CA USA
[2] Univ Calif Riverside, Endocrinol & Obes Med, Riverside, CA 92521 USA
关键词
fgf-23; hyperphosphaturia; hypophosphatemia; osteomalacia; tumor -induced osteomalacia;
D O I
10.7759/cureus.54712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor-induced osteomalacia (TIO) is a rare complication of certain tumors involving the skeletal bones, mainly in the lower extremities and rarely the spine, that can cause skeletal abnormalities, osteopenia, and osteoporosis. The etiology of these tumors is unknown, and they are considered benign tumors that usually localize in bone or soft tissue anywhere in the body. Symptoms are nonspecific and vague, which causes a delay in diagnosis. These tumors produce fibroblast growth factor-23, which causes hypophosphatemia due to renal wasting of phosphate and inhibits vitamin D3 activation, resulting in osteomalacia. The majority of these tumors are osteoblastic and rarely osteolytic. A PET scan can detect the location and diagnose these tumors. Surgical resection, when feasible, is the treatment of choice and can lead to improvement, resolution of symptoms, and correction of hypophosphatemia. Patients usually present with a wide variety of nonspecific complaints. This case report presents an unusual presentation of TIO from a phosphaturic mesenchymal tumor involving the left acetabulum.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Burosumab in tumor-induced osteomalacia: A case report
    Day, Alvin Lee
    Gutierrez, Orlando M.
    Guthrie, Barton L.
    Saag, Kenneth G.
    JOINT BONE SPINE, 2020, 87 (01) : 81 - 83
  • [22] Challenges in the management of tumor-induced osteomalacia (TIO)
    Brandi, Maria Luisa
    Clunie, Gavin P. R.
    Houillier, Pascal
    de Beur, Suzanne M. Jan
    Minisola, Salvatore
    Oheim, Ralf
    Seefried, Lothar
    BONE, 2021, 152
  • [23] Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report
    Zhang, Yifan
    Hu, Mingwei
    Guo, Cuicui
    Yang, Xue
    Xiang, Shuai
    Xu, Hao
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [24] Tumor-induced osteomalacia: a case report
    Romualdo-Silva, Daniel Dutra
    Carvalho Silva, Barbara Campolina
    Caetano, Cristiane Vasconcelos
    Franca Paiva Tiburcio, Angelica Maria
    Nunes, Mauricio Buzelin
    Pinheiro Chagas, Sergio Almeida
    Laurenti Polito, Elizandra Tomazela
    Ferreira, Antonio Rodrigues
    Purisch, Saulo
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2009, 53 (03) : 378 - 382
  • [25] Treatment Advances in Tumor-Induced Osteomalacia
    Hartley, Iris R.
    Roszko, Kelly L.
    CALCIFIED TISSUE INTERNATIONAL, 2025, 116 (01)
  • [26] Epidemiology of Tumor-Induced Osteomalacia in Denmark
    Abrahamsen, Bo
    Smith, Christopher D.
    Minisola, Salvatore
    CALCIFIED TISSUE INTERNATIONAL, 2021, 109 (02) : 147 - 156
  • [27] Epidemiology of Tumor-Induced Osteomalacia in Denmark
    Bo Abrahamsen
    Christopher D. Smith
    Salvatore Minisola
    Calcified Tissue International, 2021, 109 : 147 - 156
  • [28] Tumor-induced osteomalacia: rhinosinusal hemangiopericytoma
    Serafini, Enriqueta M.
    Pisarevsky, Ana A.
    Plumet Garrido, Javier
    Zamora, Rafael J.
    Petrucci, Enrique A.
    MEDICINA-BUENOS AIRES, 2013, 73 (01) : 39 - 42
  • [29] Tumor-Induced Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Sole Presenting as a Crippling Illness in a Postmenopausal Woman
    Fang, Xiang
    Zhang, Wenli
    Yu, Zeping
    Liu, Hongyuan
    Xiong, Yan
    Luo, Yi
    Song, Liuhong
    Li, Jing
    Duan, Hong
    JOURNAL OF FOOT & ANKLE SURGERY, 2020, 59 (05): : 1113 - 1117
  • [30] Phosphaturic Mesenchymal Tumor: A Single Case Report Discussing Diagnostic and Therapeutic Challenges of Tumor-Induced Osteomalacia
    Homlar, Kelly
    Sullivan, Brian T.
    Sharma, Suash
    AJSP-REVIEWS AND REPORTS, 2018, 23 (06): : 296 - 300